In vitro reduction of mycotoxins and other inflammatory mediators from whole blood using CytoSorb® hemoadsorbent polymer beads
Chan P.P., Golobish T.D., Gruda M.C., Guliashvili T., O’Sullivan P., Rueggeberg K.-G., Scheirer A.R., CytoSorbents Corporation, US
Opportunistic fungal infections account for up to 25% of all hospital-acquired blood infections. Patients at highest risk are those with weakened immune systems, and include elderly patients, patients with cancer or HIV infection, and patients [...]